The American Association of Clinical Endocrinologists/American College of Endocrinology consensus statement also recommends either a GLP-1RA or SGLT2i as a preferred treatment option (either as first-line or, more typically, second-line treatment after metformin) over alternative options such as a dipeptidyl peptidase-4 inhibitor, a thiazolidinedione (TZD), or a sulfonylurea (SU), for patients with T2D and ASCVD, stage 3 CKD, or heart failure with reduced ejection fraction [2]
And as of now, Medicare may make eligible about 3 million patients which have both heart disease and obesity for Wegovy
Our clinicians at DevotedDOc work closely with patients to evaluate these factors and create personalized treatment plans
Utilizar dentro de 35-40 das
Wellness & longevity FAQs What are vitamin IV drips and how do they work
Preparation is everything